Indoco Remedies Limited INDOCO

Latest filings

• Routine15 28 Sept, 14:45 · BSE
  Intimation regarding Closure of Trading Window
• Routine18 24 Sept, 12:37 · NSE
  Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ESG rating
• M&A70 18 Sept, 18:01 · NSE
  Approval of the Committee of Executive DIrectors for incorporation of the wholly owned subsidiary Warren Lifesciences Private Limited
• Routine15 18 Sept, 13:27 · NSE
  Voting results.
• Routine15 17 Sept, 13:14 · NSE
  Proceedings of Annual General Meeting held on September 17, 2026
• General25 10 Sept, 12:51 · NSE
  Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 UK MHRA inspection at Company's manufacturing facility at Plant I (solid oral dosage form) located at Goa.
• Insider / SAST45 10 Sept, 09:35 · BSE
  The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Aditi M Panandikar & Others
• Approval73 5 Sept, 13:37 · NSE
  'Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015- USFDA Inspection at Company's manufacturing facility at Plant II (Sterile) located at Goa'.
• Insider / SAST45 3 Sept, 10:07 · BSE
  Indoco Remedies Ltd - 532612 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
• Insider / SAST45 1 Sept, 10:46 · BSE
  Indoco Remedies Ltd - 532612 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

Shown 15 minutes after publication. Real time with Pro.

Upcoming corporate actions

No announced actions in the next 60 days.